Copyright Reports & Markets. All rights reserved.

Global Human Milk Oligosaccharides (HMO) Market Growth 2019-2024

Buy now

Table of Contents

    2019-2024 Global Human Milk Oligosaccharides (HMO) Consumption Market Report

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Human Milk Oligosaccharides (HMO) Consumption 2014-2024
        • 2.1.2 Human Milk Oligosaccharides (HMO) Consumption CAGR by Region
      • 2.2 Human Milk Oligosaccharides (HMO) Segment by Type
        • 2.2.1 Neutral
        • 2.2.2 Acidic
      • 2.3 Human Milk Oligosaccharides (HMO) Consumption by Type
        • 2.3.1 Global Human Milk Oligosaccharides (HMO) Consumption Market Share by Type (2014-2019)
        • 2.3.2 Global Human Milk Oligosaccharides (HMO) Revenue and Market Share by Type (2014-2019)
        • 2.3.3 Global Human Milk Oligosaccharides (HMO) Sale Price by Type (2014-2019)
      • 2.4 Human Milk Oligosaccharides (HMO) Segment by Application
        • 2.4.1 Food Industry
        • 2.4.2 Laboratory Research
      • 2.5 Human Milk Oligosaccharides (HMO) Consumption by Application
        • 2.5.1 Global Human Milk Oligosaccharides (HMO) Consumption Market Share by Application (2014-2019)
        • 2.5.2 Global Human Milk Oligosaccharides (HMO) Value and Market Share by Application (2014-2019)
        • 2.5.3 Global Human Milk Oligosaccharides (HMO) Sale Price by Application (2014-2019)

      3 Global Human Milk Oligosaccharides (HMO) by Players

      • 3.1 Global Human Milk Oligosaccharides (HMO) Sales Market Share by Players
        • 3.1.1 Global Human Milk Oligosaccharides (HMO) Sales by Players (2017-2019)
        • 3.1.2 Global Human Milk Oligosaccharides (HMO) Sales Market Share by Players (2017-2019)
      • 3.2 Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Players
        • 3.2.1 Global Human Milk Oligosaccharides (HMO) Revenue by Players (2017-2019)
        • 3.2.2 Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Players (2017-2019)
      • 3.3 Global Human Milk Oligosaccharides (HMO) Sale Price by Players
      • 3.4 Global Human Milk Oligosaccharides (HMO) Manufacturing Base Distribution, Sales Area, Product Types by Players
        • 3.4.1 Global Human Milk Oligosaccharides (HMO) Manufacturing Base Distribution and Sales Area by Players
        • 3.4.2 Players Human Milk Oligosaccharides (HMO) Products Offered
      • 3.5 Market Concentration Rate Analysis
        • 3.5.1 Competition Landscape Analysis
        • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.6 New Products and Potential Entrants
      • 3.7 Mergers & Acquisitions, Expansion

      4 Human Milk Oligosaccharides (HMO) by Regions

      • 4.1 Human Milk Oligosaccharides (HMO) by Regions
        • 4.1.1 Global Human Milk Oligosaccharides (HMO) Consumption by Regions
        • 4.1.2 Global Human Milk Oligosaccharides (HMO) Value by Regions
      • 4.2 Americas Human Milk Oligosaccharides (HMO) Consumption Growth
      • 4.3 APAC Human Milk Oligosaccharides (HMO) Consumption Growth
      • 4.4 Europe Human Milk Oligosaccharides (HMO) Consumption Growth
      • 4.5 Middle East & Africa Human Milk Oligosaccharides (HMO) Consumption Growth

      5 Americas

      • 5.1 Americas Human Milk Oligosaccharides (HMO) Consumption by Countries
        • 5.1.1 Americas Human Milk Oligosaccharides (HMO) Consumption by Countries (2014-2019)
        • 5.1.2 Americas Human Milk Oligosaccharides (HMO) Value by Countries (2014-2019)
      • 5.2 Americas Human Milk Oligosaccharides (HMO) Consumption by Type
      • 5.3 Americas Human Milk Oligosaccharides (HMO) Consumption by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Human Milk Oligosaccharides (HMO) Consumption by Countries
        • 6.1.1 APAC Human Milk Oligosaccharides (HMO) Consumption by Countries (2014-2019)
        • 6.1.2 APAC Human Milk Oligosaccharides (HMO) Value by Countries (2014-2019)
      • 6.2 APAC Human Milk Oligosaccharides (HMO) Consumption by Type
      • 6.3 APAC Human Milk Oligosaccharides (HMO) Consumption by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Human Milk Oligosaccharides (HMO) by Countries
        • 7.1.1 Europe Human Milk Oligosaccharides (HMO) Consumption by Countries (2014-2019)
        • 7.1.2 Europe Human Milk Oligosaccharides (HMO) Value by Countries (2014-2019)
      • 7.2 Europe Human Milk Oligosaccharides (HMO) Consumption by Type
      • 7.3 Europe Human Milk Oligosaccharides (HMO) Consumption by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Human Milk Oligosaccharides (HMO) by Countries
        • 8.1.1 Middle East & Africa Human Milk Oligosaccharides (HMO) Consumption by Countries (2014-2019)
        • 8.1.2 Middle East & Africa Human Milk Oligosaccharides (HMO) Value by Countries (2014-2019)
      • 8.2 Middle East & Africa Human Milk Oligosaccharides (HMO) Consumption by Type
      • 8.3 Middle East & Africa Human Milk Oligosaccharides (HMO) Consumption by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Marketing, Distributors and Customer

      • 10.1 Sales Channel
        • 10.1.1 Direct Channels
        • 10.1.2 Indirect Channels
      • 10.2 Human Milk Oligosaccharides (HMO) Distributors
      • 10.3 Human Milk Oligosaccharides (HMO) Customer

      11 Global Human Milk Oligosaccharides (HMO) Market Forecast

      • 11.1 Global Human Milk Oligosaccharides (HMO) Consumption Forecast (2019-2024)
      • 11.2 Global Human Milk Oligosaccharides (HMO) Forecast by Regions
        • 11.2.1 Global Human Milk Oligosaccharides (HMO) Forecast by Regions (2019-2024)
        • 11.2.2 Global Human Milk Oligosaccharides (HMO) Value Forecast by Regions (2019-2024)
        • 11.2.3 Americas Consumption Forecast
        • 11.2.4 APAC Consumption Forecast
        • 11.2.5 Europe Consumption Forecast
        • 11.2.6 Middle East & Africa Consumption Forecast
      • 11.3 Americas Forecast by Countries
        • 11.3.1 United States Market Forecast
        • 11.3.2 Canada Market Forecast
        • 11.3.3 Mexico Market Forecast
        • 11.3.4 Brazil Market Forecast
      • 11.4 APAC Forecast by Countries
        • 11.4.1 China Market Forecast
        • 11.4.2 Japan Market Forecast
        • 11.4.3 Korea Market Forecast
        • 11.4.4 Southeast Asia Market Forecast
        • 11.4.5 India Market Forecast
        • 11.4.6 Australia Market Forecast
      • 11.5 Europe Forecast by Countries
        • 11.5.1 Germany Market Forecast
        • 11.5.2 France Market Forecast
        • 11.5.3 UK Market Forecast
        • 11.5.4 Italy Market Forecast
        • 11.5.5 Russia Market Forecast
        • 11.5.6 Spain Market Forecast
      • 11.6 Middle East & Africa Forecast by Countries
        • 11.6.1 Egypt Market Forecast
        • 11.6.2 South Africa Market Forecast
        • 11.6.3 Israel Market Forecast
        • 11.6.4 Turkey Market Forecast
        • 11.6.5 GCC Countries Market Forecast
      • 11.7 Global Human Milk Oligosaccharides (HMO) Forecast by Type
      • 11.8 Global Human Milk Oligosaccharides (HMO) Forecast by Application

      12 Key Players Analysis

      • 12.1 Abbott
        • 12.1.1 Company Details
        • 12.1.2 Human Milk Oligosaccharides (HMO) Product Offered
        • 12.1.3 Abbott Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.1.4 Main Business Overview
        • 12.1.5 Abbott News
      • 12.2 Inbiose
        • 12.2.1 Company Details
        • 12.2.2 Human Milk Oligosaccharides (HMO) Product Offered
        • 12.2.3 Inbiose Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.2.4 Main Business Overview
        • 12.2.5 Inbiose News
      • 12.3 Company two
        • 12.3.1 Company Details
        • 12.3.2 Human Milk Oligosaccharides (HMO) Product Offered
        • 12.3.3 Company two Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.3.4 Main Business Overview
        • 12.3.5 Company two News
      • 12.4 Jennewein Biotechnologie
        • 12.4.1 Company Details
        • 12.4.2 Human Milk Oligosaccharides (HMO) Product Offered
        • 12.4.3 Jennewein Biotechnologie Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.4.4 Main Business Overview
        • 12.4.5 Jennewein Biotechnologie News
      • 12.5 Glycom
        • 12.5.1 Company Details
        • 12.5.2 Human Milk Oligosaccharides (HMO) Product Offered
        • 12.5.3 Glycom Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.5.4 Main Business Overview
        • 12.5.5 Glycom News
      • 12.6 ZuChem
        • 12.6.1 Company Details
        • 12.6.2 Human Milk Oligosaccharides (HMO) Product Offered
        • 12.6.3 ZuChem Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.6.4 Main Business Overview
        • 12.6.5 ZuChem News
      • 12.7 Dextra Laboratories
        • 12.7.1 Company Details
        • 12.7.2 Human Milk Oligosaccharides (HMO) Product Offered
        • 12.7.3 Dextra Laboratories Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.7.4 Main Business Overview
        • 12.7.5 Dextra Laboratories News

      ...

        13 Research Findings and Conclusion

        Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces.

        According to this study, over the next five years the Human Milk Oligosaccharides (HMO) market will register a 27.1% CAGR in terms of revenue, the global market size will reach US$ 450 million by 2024, from US$ 110 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Human Milk Oligosaccharides (HMO) business, shared in Chapter 3.

        This report presents a comprehensive overview, market shares, and growth opportunities of Human Milk Oligosaccharides (HMO) market by product type, application, key manufacturers and key regions and countries.

        This study considers the Human Milk Oligosaccharides (HMO) value and volume generated from the sales of the following segments:

        Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
        Neutral
        Acidic
        Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
        Food Industry
        Laboratory Research

        This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
        Americas
        United States
        Canada
        Mexico
        Brazil
        APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
        Europe
        Germany
        France
        UK
        Italy
        Russia
        Spain
        Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

        The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
        Abbott
        Inbiose
        Company two
        Jennewein Biotechnologie
        Glycom
        ZuChem
        Dextra Laboratories
        ...

        In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

        Research objectives
        To study and analyze the global Human Milk Oligosaccharides (HMO) consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
        To understand the structure of Human Milk Oligosaccharides (HMO) market by identifying its various subsegments.
        Focuses on the key global Human Milk Oligosaccharides (HMO) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
        To analyze the Human Milk Oligosaccharides (HMO) with respect to individual growth trends, future prospects, and their contribution to the total market.
        To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
        To project the consumption of Human Milk Oligosaccharides (HMO) submarkets, with respect to key regions (along with their respective key countries).
        To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
        To strategically profile the key players and comprehensively analyze their growth strategies.

        Buy now